Stock Snapshot for NYSE: BDX

About BD

BD is a global medical technology company that is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care.

70,000+

BD Associates

190+

Countries Served

34B+

Devices Made Annually

$1B+

Annual R&D Spending

33,000+

Active Patents

As of Jan 24, 2023 • Annual Meeting of Shareholders Presentation

For complete information regarding our financials, see our periodic filings

Latest Financial Results

$5.0B

Q3 2024 Total BD Revenue

$3.50

Q3 2024 Adjusted EPS*

Source: Q3 2024 Earning Press Release
* Non-GAAP Financial Measures. View full reconciliation in our Q3 earnings press release.

For complete information regarding our financials, see our periodic filings

Latest Annual Report

For Fiscal Year Ending Sep 30, 2023

Latest News

BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation

View Press Release

New Data Reveals BD's Artificial Intelligence Software Highly Effective in Detecting Indicators of Controlled Substance Diversion

View Press Release

BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics

View Press Release

See How BD Solutions Advance Care Across The Patient Journey

Learn More

Together We Advance

Our ESG strategy—a four-pillar framework called Together We Advance—embraces the connections and interdependence between company health, planet health, community health and human health. Through this framework, we address the most relevant ESG issues for our business and stakeholders.

View ESG Efforts

Featured Reports

2023 Annual Report

2023 Annual Report

Download Report
2023 Sustainability Report

2023 Sustainability Report

Download Report
2022 Inclusion, Diversity and Equity Report

2022 Inclusion, Diversity and Equity Report

Download Report
2022 Cybersecurity Annual Report

2022 Cybersecurity Annual Report

Download Report

IR Contacts

Corporate Office

Becton, Dickinson and Company
1 Becton Drive
Franklin Lakes, NJ 07417
United States
800.284.6845

Investor Relations

Becton, Dickinson and Company
800.284.6845
investor_relations@bd.com

Transfer Agent

Computershare Trust Company, N.A.
P.O. Box 43006
Providence, RI 02940-3066
877.498.8861
computershare@computershare.com
https://www.computershare.com


Overnight Mail Address
150 Royall St., Suite 101
Canton, MA 02021